Company Filing History:
Years Active: 2024
Title: Anna Schleicher: Innovator in T Cell Enrichment
Introduction
Anna Schleicher is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of immunotherapy, particularly in the enrichment of T cells. Her innovative work has the potential to advance treatments for various diseases, including cancer.
Latest Patents
Anna holds a patent for her invention titled "Enrichment of T cells using an anti-Cβ antibody." This patent describes methods and uses of antibodies targeting the Cβ1 or the Cβ2 chain of a T cell receptor (TCR), specifically an anti-Cβ1 antibody. The invention focuses on the enrichment of T cells expressing a desired antigen-specific recombinant T cell receptor, which is crucial for developing targeted immunotherapies.
Career Highlights
Anna is currently employed at Medigene Immunotherapies GmbH, a company dedicated to developing innovative immunotherapies. Her work at Medigene has positioned her as a key player in the field of T cell research and therapy.
Collaborations
Anna collaborates with notable colleagues, including Daniel Sommermeyer and Slavoljub Milosevic. Their combined expertise enhances the research and development efforts at Medigene, fostering innovation in immunotherapy.
Conclusion
Anna Schleicher's contributions to T cell enrichment and immunotherapy exemplify the impact of innovative research in medicine. Her work continues to pave the way for advancements in targeted therapies, showcasing the importance of collaboration and dedication in scientific discovery.